Short treatment duration for community-acquired pneumonia

被引:6
作者
Dinh, Aurelien [1 ,2 ,3 ,5 ]
Cremieux, Anne-Claude [4 ]
Guillemot, Didier [3 ]
机构
[1] Univ Hosp Raymond Poincare, AP HP, Ainfect Dis Unit, Garches, France
[2] Paris Saclay Univ, Antiinfect Evas & Pharmacoepidemiol Team, UVSQ, Inserm,CESP, Montigny Le Bretonneux, France
[3] Univ Paris, Inst Pasteur, Epidemiol & Modelling Antibiot Evas EMAE, Paris, France
[4] Univ Paris, St Louis Univ Hosp, Infect Dis Dept, AP HP, Paris, France
[5] Paris Saclay Univ, Univ Hosp Raymond Poincare, APHP, Infect Dis Unit, 104 Bd R Poincare, F-92380 Garches, France
关键词
antibiotic; bacterial resistance; pneumonia; treatment duration; INFECTIOUS-DISEASES-SOCIETY; ANTIBIOTIC-TREATMENT; DOUBLE-BLIND; EARLY SWITCH; HOSPITALIZED-PATIENTS; PRACTICE GUIDELINE; THORACIC-SOCIETY; BETA-LACTAM; ADULTS; RISK;
D O I
10.1097/QCO.0000000000000908
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of reviewLower respiratory tract infections are one of the most common indications for antibiotic use in community and hospital settings. Usual guidelines for adults with community-acquired pneumonia (CAP) recommend 5-7 days of antibiotic treatment. In daily practice, physicians often prescribe 9-10 days of antibiotic treatment. Among available strategies to decrease antibiotic use, possibly preventing the emergence of bacterial resistance, reducing treatment durations is the safest and the most acceptable to clinicians. We aim to review data evaluating the efficacy of short antibiotic duration in adult CAP and which criteria can help clinicians to reduce antibiotic treatment.Recent findingsSeveral studies and meta-analyses demonstrated that the treatment duration of 7 days or less was sufficient for CAP. Two trials found that 3-day treatments were effective, even in hospitalized CAP.To customize and shorten duration, clinical and biological criteria have been studied and reflect patient's response. Indeed, stability criteria were recently shown to be effective to discontinue antibiotic treatment. Procalcitonin was also studied but never compared with clinical criteria.Treatment duration for CAP is still under debate, but several studies support short durations. Clinical criteria could be possibly used to discontinue antibiotic treatment.
引用
收藏
页码:140 / 145
页数:6
相关论文
共 63 条
[1]  
[Anonymous], 2019, ANTIBIOTIC THERAPY R
[2]  
[Anonymous], 2020, The top 10 causes of death. Top ten causes of death
[3]   The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].
Austin, DJ ;
Kristinsson, KG ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156
[4]   Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure [J].
Baggs, James ;
Jernigan, John A. ;
Halpin, Alison Laufer ;
Epstein, Lauren ;
Hatfield, Kelly M. ;
McDonald, L. Clifford .
CLINICAL INFECTIOUS DISEASES, 2018, 66 (07) :1004-1012
[5]   Pyocalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations [J].
Becker, Kenneth L. ;
Snider, Richard ;
Nylen, Eric S. .
CRITICAL CARE MEDICINE, 2008, 36 (03) :941-952
[6]   Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae [J].
Bernard, J. ;
Armand-Lefevre, L. ;
Luce, E. ;
El Mniai, A. ;
Chau, F. ;
Casalino, E. ;
Andremont, A. ;
Ruppe, E. .
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (07) :646.e1-646.e4
[7]   Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial [J].
Bernard, Louis ;
Dinh, Aurelien ;
Ghout, Idir ;
Simo, David ;
Zeller, Valerie ;
Issartel, Bertrand ;
Le Moing, Vincent ;
Belmatoug, Nadia ;
Lesprit, Philippe ;
Bru, Jean-Pierre ;
Therby, Audrey ;
Bouhour, Damien ;
Denes, Eric ;
Debard, Alexa ;
Chirouze, Catherine ;
Fevre, Karine ;
Dupon, Michel ;
Aegerter, Philippe ;
Mulleman, Denis .
LANCET, 2015, 385 (9971) :875-882
[8]   Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial [J].
Bouadma, Lila ;
Luyt, Charles-Edouard ;
Tubach, Florence ;
Cracco, Christophe ;
Alvarez, Antonio ;
Schwebel, Carole ;
Schortgen, Frederique ;
Lasocki, Sigismond ;
Veber, Benoit ;
Dehoux, Monique ;
Bernard, Maguy ;
Pasquet, Blandine ;
Regnier, Bernard ;
Brun-Buisson, Christian ;
Chastre, Jean ;
Wolff, Michel .
LANCET, 2010, 375 (9713) :463-474
[9]   Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events [J].
Branch-Elliman, Westyn ;
O'Brien, William ;
Strymish, Judith ;
Itani, Kamal ;
Wyatt, Christina ;
Gupta, Kalpana .
JAMA SURGERY, 2019, 154 (07) :590-598
[10]   Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial [J].
Chastre, J ;
Wolff, M ;
Fagon, JY ;
Chevret, S ;
Thomas, F ;
Wermert, D ;
Clementi, E ;
Gonzalez, J ;
Jusserand, D ;
Asfar, P ;
Perrin, D ;
Fieux, F ;
Aubas, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19) :2588-2598